Pediatric Myopia Treatment Study

Multicenter study of the Safety and Efficacy of OT-101 (Atropine Sulfate 0.01%) in Treating the Progression of Myopia in Pediatric Subjects

girl with eye glasses doing homework

 

AGE: 3-15 years old
SEX AT BIRTH: All
TYPE: Interventional Drug Study
CONDITION: Myopia, Progressive
HEALTHY PARTICIPANTS: No
LOCATION: University Hospitals Cleveland Medical Center

Learn More About This Research Study

For more information, please contact study coordinator, Barbara-Georgeia Stephens at 216-844-0027 or complete the form below.

Study Purpose

The purpose of this research study is to determine if the investigational eye drop OT-101 can treat the progression of myopia.

Who Can Participate

Participants between 3 and 15 years old diagnosed with myopia may be eligible for this study.

Request More Information

To learn more about this study, please fill out the form below to request more information.

XXX-XXX-XXXX